Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

891 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.
Schmitz FJ, Hofmann B, Hansen B, Scheuring S, Lückefahr M, Klootwijk M, Verhoef J, Fluit A, Heinz HP, Köhrer K, Jones ME. Schmitz FJ, et al. Among authors: jones me. J Antimicrob Chemother. 1998 Apr;41(4):481-4. doi: 10.1093/jac/41.4.481. J Antimicrob Chemother. 1998. PMID: 9598779
Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.
Schmitz FJ, Jones ME, Hofmann B, Hansen B, Scheuring S, Lückefahr M, Fluit A, Verhoef J, Hadding U, Heinz HP, Köhrer K. Schmitz FJ, et al. Among authors: jones me. Antimicrob Agents Chemother. 1998 May;42(5):1249-52. doi: 10.1128/AAC.42.5.1249. Antimicrob Agents Chemother. 1998. PMID: 9593159 Free PMC article.
Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains.
Schmitz FJ, Hertel B, Hofmann B, Scheuring S, Verhoef J, Fluit AC, Heinz HP, Köhrer K, Jones ME. Schmitz FJ, et al. Among authors: jones me. J Antimicrob Chemother. 1998 Oct;42(4):561-3. doi: 10.1093/jac/42.4.561. J Antimicrob Chemother. 1998. PMID: 9818767 No abstract available.
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
Jones ME, Visser MR, Klootwijk M, Heisig P, Verhoef J, Schmitz FJ. Jones ME, et al. Antimicrob Agents Chemother. 1999 Feb;43(2):421-3. doi: 10.1128/AAC.43.2.421. Antimicrob Agents Chemother. 1999. PMID: 9925551 Free PMC article.
Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory season.
Jones ME, Sahm DF, Martin N, Scheuring S, Heisig P, Thornsberry C, Köhrer K, Schmitz FJ. Jones ME, et al. Antimicrob Agents Chemother. 2000 Feb;44(2):462-6. doi: 10.1128/AAC.44.2.462-466.2000. Antimicrob Agents Chemother. 2000. PMID: 10639387 Free PMC article.
891 results